Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Track this trialThe 50 most recent of 422 record versions are accounted for below. See every version on ClinicalTrials.gov ↗
| NCT Number | NCT04387656 |
| Lead Sponsor | National Cancer Institute (NCI) |
| Conditions (from sponsor) |
COVID-19 Infection, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm |
| Related terms | COVID-19, Neoplasm Metastasis |
| Enrollment | 1,877 participants |
| Start Date | |
| Primary Completion | (estimated) |
| Study Completion | (estimated) |
| Updated on ClinicalTrials.gov |